Maria Cannito received her Bachelor of Science degree in Pharmacy from Albany College of Pharmacy, Union University, a Master of Science degree in Health Systems Administration from Rochester Institute of Technology and a Doctor of Pharmacy degree from Shenandoah University. She began her career in hospital pharmacy, specializing in Critical Care, Institutional Review Boards, Pharmacy & Therapeutics Committees and Drug Information.

Maria joined Pfizer in 1998 as a Clinical Education Consultant providing education and drug therapy evaluations in multiple therapeutic areas. She subsequently transitioned to the Clinical Applications Team where she worked on strategies for medication adherence and development of analytic software tools. Maria continued her career with Pfizer as a Medical Outcomes Specialist where she worked with products in over 15 therapeutic areas over 7 years. She has also worked as a Field Medical Director (FMD) on both the Rare Disease and the Inflammation & Immunology Teams. Maria is currently the Team Lead for the Rare Disease Amyloidosis Field Medical Directors. Maria has numerous professional publications/presentations to her credit, including those at local, state, and national levels as well as many Pfizer awards. She is currently active in several professional organizations, including the American College of Clinical Pharmacy, American Society of Health System Pharmacists and the National Pharmacy Quality Alliance. Maria is a Past President of the Rochester Area Society of Health System Pharmacists and was recently awarded Pharmacist of the Year in 2017.

Michael S. Macko is an Assistant U.S. Attorney in the Eastern District of Pennsylvania, where he handles False Claims Act litigation, investigations, and other matters in the Civil Division. Mr. Macko graduated cum laude from the University of Pennsylvania Law School and clerked for judges in the U.S. Court of Appeals for the Third Circuit and U.S. District Court. Before joining the Department of Justice in 2010, Mr. Macko worked as a Litigation Associate at an international law firm in Philadelphia.

Martin Marciniak, RPh, MPP, PhD is Vice President, US Medical Affairs responsible for Customer Engagement, Value, Evidence and Outcomes within GlaxoSmithKline. His leadership and research experience has included specific therapeutic area focus in oncology, neuroscience, cardiovascular disease, policy and economics. He has published in peer-reviewed journals and has been invited to present clinical, health outcomes, and economic results at both national and international meetings. In addition to his research activities, Martin has previously served as a nonvoting industry representative to the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) for the Centers for Medicare and Medicaid Services and as a board member for the National Pharmaceutical Council (NPC) Board of Directors. Presently, he serves as a member of the National Quality Forum Efficiency Steering Committee, the Editorial Advisory Board for Value and Outcomes Spotlight (an ISPOR publication), and on the advisory board for the Institute for Clinical and Economic Review (ICER). In addition to these activities, he has also served the broader healthcare community in several different ways, most recently through invitations to engage in public forum discussions at SCOPE, Eye for Pharma, BioCentury TV and the FDA/CMS Summit.

Martin holds a position of Adjunct Assistant Professor in the Division of Pharmaceutical Outcomes and Policy at the University of North Carolina’s Eshelman School of Pharmacy. He received his Ph.D. from the University of California at Berkeley, his masters’ degree in Public Policy from Harvard University, and his BS in Pharmacy from Purdue University.

Michael R. Ujhelyi, Pharm.D., FCCP is Senior Regional Medical Director for BTG leading the Interventional Oncology field medical team.  The  medical  team  is responsible  for  therapy  training  and  education,  clinical  trial  liaison/investigator  initiated  research,  executing  medical  plans  and  supporting  internal  stakeholders.

Previously Dr. Ujhelyi was:

• Vice President Research and Scientific Affairs: Minneapolis Heart Institute Foundation (2016-2017)
• Medical Affairs and Clinical Research Director:  Medtronic Neuromodulation and Cardiac Rhythm  business units respectively at Medtronic (1998 – 2016). 
• Associate Professor of Pharmacy and Medicine:  University of Georgia College of Pharmacy and Medical college of Georgia (1993-1998)    

Dr. Ujhelyi has designed and developed many programs including an investigator initiated research program, field based medical scientist program, oncology medical science liaison organization, medical evidence centers and medical information program. He has led large clinical research initiatives, developed cardiovascular device based therapies and has published over 70 research papers, presented more than 100 research papers at scientific meetings and has 26 issued patents; one patent was recently FDA approved and commercialized.

Dr Ujhelyi received his Bachelor of Science in Pharmacy from the University of Florida (1987), Doctor of Pharmacy from the University of North Carolina at Chapel Hill (1989) and completed a Cardiovascular Therapeutics Fellowship at Hartford Hospital and University of Connecticut (1991).

Prior to Rolando’s entrance in the Pharmaceutical Industry, he held various roles, including Clinical Coordinator at a mid-sized community hospital in South Florida and then later was the Clinical Project Manager working exclusively with Florida Medicaid where he led many clinical initiatives. For over the past 13 years within Pharma, Rolando worked as a Managed Market MSL for Johnson and Johnson before transitioning over to Senior Neuroscience MSL. He later accepted a position at Lundbeck where he worked for over four years and helped launch multiple products. Currently, Rolando is a Regional Director to MSLs at SK Life Science. Rolando received his PharmD degree from Nova-Southeastern University and currently resides in Jupiter, Florida with wife and two sons.